Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Efficacy and safety of the combination of camrelizumab and apatinib in the treatment of liver cancer: a systematic review and single-arm meta-analysis

Fig. 3

A Forest plot illustrating DCR of camrelizumab combined with apatinib for liver cancer treatment; B Forest plot delineating mPFS of camrelizumab in combination with apatinib for liver cancer treatment; C Sensitivity analysis on mPFS of camrelizumab in combination with apatinib for liver cancer treatment; D Forest plot illustrating mOS of camrelizumab combined with apatinib for liver cancer treatment

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us